HK1207370A1 - Crystal structures of sglt2 inhibitors and processes for preparing same sglt2 - Google Patents

Crystal structures of sglt2 inhibitors and processes for preparing same sglt2

Info

Publication number
HK1207370A1
HK1207370A1 HK15107967.7A HK15107967A HK1207370A1 HK 1207370 A1 HK1207370 A1 HK 1207370A1 HK 15107967 A HK15107967 A HK 15107967A HK 1207370 A1 HK1207370 A1 HK 1207370A1
Authority
HK
Hong Kong
Prior art keywords
sglt2
processes
crystal structures
preparing same
inhibitors
Prior art date
Application number
HK15107967.7A
Other languages
Chinese (zh)
Inventor
．古古塔斯
．洛賓格
．羅摩克里斯納
．德什潘德
．比恩
賴佳仁
王貞棋
．里布爾
．格羅索
．尼爾希
．辛格
．迪馬科
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1207370A1 publication Critical patent/HK1207370A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15107967.7A 2007-12-27 2015-08-18 Crystal structures of sglt2 inhibitors and processes for preparing same sglt2 HK1207370A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410548661.8A CN104387354A (en) 2007-12-27 2007-12-27 Crystal structures and preparation methods of SGLT2 inhibitors

Publications (1)

Publication Number Publication Date
HK1207370A1 true HK1207370A1 (en) 2016-01-29

Family

ID=52605330

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107967.7A HK1207370A1 (en) 2007-12-27 2015-08-18 Crystal structures of sglt2 inhibitors and processes for preparing same sglt2

Country Status (2)

Country Link
CN (1) CN104387354A (en)
HK (1) HK1207370A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515117B2 (en) * 1999-10-12 2003-02-04 Bristol-Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
WO2002083066A2 (en) * 2001-04-11 2002-10-24 Bristol-Myers Squibb Company Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
US7375213B2 (en) * 2003-01-03 2008-05-20 Bristol-Myers Squibb Company Methods of producing C-aryl glucoside SGLT2 inhibitors
US7919598B2 (en) * 2006-06-28 2011-04-05 Bristol-Myers Squibb Company Crystal structures of SGLT2 inhibitors and processes for preparing same

Also Published As

Publication number Publication date
CN104387354A (en) 2015-03-04

Similar Documents

Publication Publication Date Title
IL238338A0 (en) Processes for the preparation of sglt2 inhibitors
IL219094A (en) Process for the preparation of sglt2 inhibitors and sglt2 inhibitors produced thereby
IL232786A0 (en) Inhibitors of e1 activating enzyme
IL200576A0 (en) Inhibitors of rtp801 and their uses
EP2424857A4 (en) Dual-action inhibitors and methods of using same
EP2026843A4 (en) Therapeutic uses of inhibitors of rtp801l
EP2191458A4 (en) Finger-worn devices and related methods of use
PL2176028T3 (en) Methods of crystallographically reorienting single crystal bodies
EP2122054A4 (en) Nonwoven panel and method of construction thereof
EP2162482A4 (en) Singly-terminated polyisobutylenes and process for making same
IL197006A0 (en) Crystal forms of 9-hydroxy-risperidone (paliperidone)
EP2484815A4 (en) Sic single crystal and method for producing same
HK1144580A1 (en) Crystal structures of neuropilin fragments and neuropilin-antibody complexes
ZA201000482B (en) Process for the synthesis of e1 activating enzyme inhibitors
IL190724A0 (en) Crystalline forms of dolasetron base and proceses for preparation thereof
IL210098A0 (en) Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
PL2030956T3 (en) Mineral adhesive agent and method for its manufacture
IL213973A0 (en) Salt of tetrahydrotriazolopyridine derivative and crystal thereof
SI2695865T1 (en) Mineral adhesive agent and method for its manufacture
IL201603A0 (en) Crystalline forms of topotecan hydrochloride and processes for making the same
HK1207370A1 (en) Crystal structures of sglt2 inhibitors and processes for preparing same sglt2
EP2017001A4 (en) Method for treatment of crystal slurry
IL211688A (en) Crystal form ii of calcium 3-acetylaminopropane-1-sulfonate
PL2462154T3 (en) Novel crystal form of cdb-4124 and process for the preparation thereof
GB0723583D0 (en) Liquid crystal device and method of manufacture thereof